The short prolactin receptor predominates in endothelial cells of micro- and macrovascular origin

Journal of Vascular Research

Volumn 44, Issue 1, 2007, Pages 19-30

  Ricken, Albert M ^a   Traenkner, Anja ^a   Merkwitz, Claudia ^a   Hummitzsch, Katja ^a   Grosche, Jens ^a,b   Spanel Borowski, Katharina ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Corpus luteum; Endothelial cells; Prolactin; Prolactin receptor

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CORPUS LUTEUM; ENDOTHELIUM CELL; ESTRUS CYCLE; FEMALE; IMMUNOFLUORESCENCE; MICROVASCULARIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN;

ANIMALS; ANTIBODIES; AORTA; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; CORPUS LUTEUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ESTROUS CYCLE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRANULOSA CELLS; MICROCIRCULATION; PROLACTIN; RECEPTORS, PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UMBILICAL VEINS;

EID: 33846224260     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097892     Document Type: Article

References (50)

1. Freeman ME, Kanyicska B, Lerant A, Nagy G: Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80:1523-1631.
2. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW: Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996;17:639-669.
3. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998;19:225-268.
4. Bentzien F, Struman I, Martini JF, Martial J, Weiner R: Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice. Cancer Res 2001;61:7356-7362.
5. Kim J, Luo W, Chen DT, Earley K, Tunstead J, Yu-Lee LY, Lin SH: Antitumor activity of the 16-kDa prolactin fragment in prostate cancer. Cancer Res 2003;63:386-393.
6. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA: Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 1999;96:1246-1251.
7. Clapp C, Lopez-Gomez FJ, Nava G, Corbacho A, Torner L, Macotela Y, Duenas Z, Ochoa A, Noris G, Acosta E, Garay E, Martinez de la Escalera G: Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: evidence for autocrine effects. J Endocrinol 1998;158:137-144.
8. Ochoa A, Montes de Oca P, Rivera JC, Duenas Z, Nava G, de La Escalera GM, Clapp C: Expression of prolactin gene and secretion of prolactin by rat retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 2001;42:1639-1645.
9. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N: Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001;412:877-884.
10. Schuler LA, Nagel RJ, Gao J, Horseman ND, Kessler MA: Prolactin receptor heterogeneity in bovine fetal and maternal tissues. Endocrinology 1997;138:3187-3194.
11. Clapp C, Weiner RI: A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 1992;130:1380-1386.
12. Merkle CJ, Schuler LA, Schaeffer RC Jr, Gribbon JM, Montgomery DW: Structural and functional effects of high prolactin levels on injured endothelial cells: evidence for an endothelial prolactin receptor. Endocrine 2000;13:37-46.
13. Stocco C, Callegari E, Gibori G: Opposite effect of prolactin and prostaglandin F(2 alpha) on the expression of luteal genes as revealed by rat cDNA expression array. Endocrinology 2001;142:4158-4161.
14. Jabbour HN, Kelly PA: Prolactin receptor subtypes: a possible mode of tissue specific regulation of prolactin function. Rev Reprod 1997;2:14-18.
15. Gaytan F, Morales C, Bellido C, Aguilar E, Sanchez-Criado JE: Role of prolactin in the regulation of macrophages and in the proliferative activity of vascular cells in newly formed and regressing rat corpora lutea. Biol Reprod 1997;57:478-486.
16. Grosdemouge I, Bachelot A, Lucas A, Baran N, Kelly PA, Binart N: Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod Biol Endocrinol 2003;1:12.
17. Kisliouk T, Levy N, Hurwitz A, Meidan R: Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J Clin Endocrinol Metab 2003;88:3700-3707.
18. Spanel-Borowski K, van der Bosch J: Different phenotypes of cultured microvessel endothelial cells obtained from bovine corpus luteum. Study by light microscopy and by scanning electron microscopy (SEM). Cell Tissue Res 1990;261:35-47.
19. Spanel-Borowski K, Ricken AM, Patton WF: Cytokeratin-positive and cytokeratin-negative cultured endothelial cells from bovine aorta and vena cava. Differentiation 1994;57:225-234.
20. Galle J, Reibiger I, Westermann M, Richter W, Loffler S: Local cell membrane deformations due to receptor-ligand bonding as seen by reflection microscopy. Cell Commun Adhes 2002;9:161-172.
21. Ireland JJ, Murphee RL, Coulson PB: Accuracy of predicting stages of bovine estrous cycle by gross appearance of the corpus luteum. J Dairy Sci 1980;63:155-160.
22. Ricken AM, Spanel-Borowski K, Saxer M, Huber PR: Cytokeratin expression in bovine corpora lutea. Histochem Cell Biol 1995;103:345-354.
23. Spanel-Borowski K, Ricken AM, Kress A, Huber PR: Isolation of granulosa-like cells from the bovine secretory corpus luteum and their characterization in long-term culture. Anat Rec 1994;239:269-279.
24. Tortonese DJ, Brooks J, Ingleton PM, McNeilly AS: Detection of prolactin receptor gene expression in the sheep pituitary gland and visualization of the specific translation of the signal in gonadotrophs. Endocrinology 1998;139:5215-5223.
25. Okamura H, Zachwieja J, Raguet S, Kelly PA: Characterization and applications of monoclonal antibodies to the prolactin receptor. Endocrinology 1989;124:2499-2508.
26. Scammell JG, Wear LB, Von Haven R: A monoclonal antibody which inhibits the biological activity of rat prolactin, but not prolactin from other species. Mol Cell Endocrinol 1990;71:125-131.
27. Sauro MD, Zorn NE: Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanism. J Cell Physiol 1991;148:133-138.
28. Nowak RA, Mora S, Diehl T, Rhoades AR, Stewart EA: Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells. Gynecol Obstet Invest 1999;48:127-132.
29. Ko JY, Ahn YL, Cho BN: Angiogenesis and white blood cell proliferation induced in mice by injection of a prolactin-expressing plasmid into muscle. Mol Cells 2003;15:262-270.
30. Corbacho AM, Macotela Y, Nava G, Torner L, Duenas Z, Noris G, Morales MA, Martinez de La Escalera G, Clapp C: Human umbilical vein endothelial cells express multiple prolactin isoforms. J Endocrinol 2000;166:53-62.
31. Davis JS, Rueda BR, Spanel-Borowski K: Microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 2003;1:89.
32. Berisha B, Schams D: Ovarian function in ruminants. Domest Anim Endocrinol 2005;29:305-317.
33. Picazo RA, Garcia Ruiz JP, Santiago Moreno J, Gonzalez de Bulnes A, Munoz J, Silvan G, Lorenzo PL, Illera JC: Cellular localization and changes in expression of prolactin receptor isoforms in sheep ovary throughout the estrous cycle. Reproduction 2004;128:545-553.
34. Clarke LA, Wathes DC, Jabbour HN: Expression and localization of prolactin receptor messenger ribonucleic acid in red deer ovary during the estrous cycle and pregnancy. Biol Reprod 1997;57:865-872.
35. Clarke DL, Arey BJ, Linzer DI: Prolactin receptor messenger ribonucleic acid expression in the ovary during the rat estrous cycle. Endocrinology 1993;133:2594-2603.
36. Anthony RV, Smith GV, Duong A, Pratt SL, Smith MF: Two forms of the prolactin receptor messenger ribonucleic acid are present in ovine feta liver and adult ovary. Endocrine 1995;3:291-295.
37. O'Neal KD, Yu-Lee LY: Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation. J Biol Chem 1994;269:26076-26082.
38. Das R, Vonderhaar BK: Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol Endocrinol 1995;9:1750-1759.
39. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, Edery M: The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol 1997;11:1449-1457.
40. McCracken JA, Custer EE, Lamsa JC: Luteolysis: a neuroendocrine-mediated event. Physiol Rev 1999;79:263-323.
41. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW: Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000;80:1-29.
42. Penny LA: Monocyte chemoattractant protein 1 in luteolysis. Rev Reprod 2000;5:63-66.
43. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI: The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 1993;133:1292-1299.
44. Binart N, Imbert-Bollore P, Baran N, Viglietta C, Kelly PA: A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice. Mol Endocrinol 2003;17:1066-1074.
45. Lesueur L, Edery M, Ali S, Paly J, Kelly PA, Djiane J: Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci USA 1991;88:824-828.
46. Hu ZZ, Meng J, Dufau ML: Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J Biol Chem 2001;276:41086-41094.
47. Qazi AM, Tsai-Morris CH, Dufau ML: Ligand-independent homo- and hetero-dimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol Endocrinol 2006;20:1912-1923.
48. Perrot-Applanat M, Gualillo O, Pezet A, Vincent V, Edery M, Kelly PA: Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol 1997;11:1020-1032.
49. Einspanier R, Pitzel L, Wuttke W, Hagendorff G, Preuss KD, Kardalinou E, Scheit KH: Demonstration of mRNAs for oxytocin and prolactin in porcine granulosa and luteal cells. Effects of these hormones on progesterone secretion in vitro. FEBS Lett 1986;204:37-40.
50. Ciereszko RE, Petroff BK, Ottobre AC, Guan Z, Stokes BT, Ottobre JS: Assessment of the mechanism by which prolactin stimulates progesterone production by early corpora lutea of pigs. J Endocrinol 1998;159:201-209.